Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in -mutant stage II and III colon cancer

Philip D Dunne, Helen G Coleman, Peter Bankhead, Matthew Alderdice, Ronan T Gray, Stephen McQuaid, Victoria Bingham, Maurice B Loughrey, Jacqueline A James, Amy M B McCorry, Alan Gilmore, Caitriona Holohan, Dirk Klingbiel, Sabine Tejpar, Patrick G Johnston, Darragh G McArt, Federica Di Nicolantonio, Daniel B Longley, Mark Lawler

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in -mutant stage II and III colon cancer'. Together they form a unique fingerprint.

Medicine and Dentistry